Concepedia

Gregory R. Carr

GR

Statistics

Publications

2

Citations

138

H-Index

2

Active since

2013

Affiliations

AstraZeneca (United Kingdom)(Current)

Gregory R. Carr is an author at AstraZeneca (United Kingdom) specializing in medicinal chemistry, drug discovery, and hormonal therapy.

Publications per year

2013–2016

2

Publications

2

Optimization of a Series of Bivalent Triazolopyridazine Based Bromodomain and Extraterminal Inhibitors: The Discovery of (3<i>R</i>)-4-[2-[4-[1-(3-Methoxy-[1,2,4]triazolo[4,3-<i>b</i>]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153)

Robert H. Bradbury, Rowena Callis, Gregory R. Carr et al. · Journal of Medicinal Chemistry · 2016 · 86 citations · Full text

, , +15

Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer

Robert H. Bradbury, David Acton, Nicola Broadbent et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 52 citations · Full text

, , +14

1–2 of 2